Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Venous Thromboembolism”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Large-scale testing (Phase 3)Study completedNCT00740883
What this trial is testing

Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study.

Who this might be right for
Pulmonary Embolism
University Hospital, Brest 374
Not applicableStudy completedNCT00266045
What this trial is testing

D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 355
Not applicableStudy completedNCT02546817
What this trial is testing

Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS

Who this might be right for
Venous Thromboembolism
Bristol-Myers Squibb 29
Post-approval studies (Phase 4)Study completedNCT01989845
What this trial is testing

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Who this might be right for
RivaroxabanCancer-associated ThrombosisRecurrence+1 more
Seoul National University Hospital 127
Not applicableStudy completedNCT02836457
What this trial is testing

ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE

Who this might be right for
Venous Thromboembolism
Bristol-Myers Squibb 1,134
Not applicableStudy completedNCT01972243
What this trial is testing

Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction Model

Who this might be right for
Venous Thromboembolism
Medical University of Vienna 800
Not applicableStudy completedNCT04979780
What this trial is testing

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsProphylaxis of Recurrent Venous Thromboembolism in Cancer Patients
Bayer 3,708
Not applicableStudy completedNCT04349189
What this trial is testing

Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait

Who this might be right for
Sickle Cell DiseaseVenous ThrombosisSickle Cell Trait+2 more
National Heart, Lung, and Blood Institute (NHLBI) 119
Not applicableStudy completedNCT00011180
What this trial is testing

Risk Factors for Venous Thromboembolism in the Community

Who this might be right for
Cardiovascular DiseasesThromboembolism
Mayo Clinic 385
Not applicableUnknownNCT03265054
What this trial is testing

Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous Thrombosis

Who this might be right for
Venous Thromboembolism (VTE)
Assistance Publique Hopitaux De Marseille 300
Large-scale testing (Phase 3)UnknownNCT04141254
What this trial is testing

Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism.

Who this might be right for
Venous Thromboembolism
University Hospital, Brest 150
Large-scale testing (Phase 3)Study completedNCT01285661
What this trial is testing

Optimal Duration of Anticoagulation in Deep Venous Thrombosis

Who this might be right for
Deep Vein Thrombosis of Lower LimbLower Extremity Deep Venous Thrombosis Recurrent
University of Padova 584
Not applicableUnknownNCT04124159
What this trial is testing

Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism

Who this might be right for
Recurrent Venous Thrombosis
Medical University of Vienna 200
Not applicableStudy completedNCT00670540
What this trial is testing

Epidemiology of Thromboembolism Disease: A Cohort Study

Who this might be right for
Vascular DiseasesEmbolism and ThrombosisPhlebitis+2 more
University Hospital, Grenoble 8,256
Large-scale testing (Phase 3)UnknownNCT00895505
What this trial is testing

D-Dimer Guided Oral Anticoagulant Treatment (OAT)

Who this might be right for
Deep Venous Thrombosis
University Hospital, Bonn 300
Not applicableWithdrawnNCT05536791
What this trial is testing

A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim
Large-scale testing (Phase 3)Ended earlyNCT05171075
What this trial is testing

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism
Anthos Therapeutics, Inc. 417
Very early researchLooking for participantsNCT06886516
What this trial is testing

Apixaban in Thrombocytopenia

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism and ThrombosisThrombocytopenia+1 more
Rushad Patell 30
Large-scale testing (Phase 3)Study completedNCT00937820
What this trial is testing

Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Astellas Pharma Inc 87